{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:47:51Z","timestamp":1785836871134,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.eprac.2025.08.010","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T04:03:39Z","timestamp":1757649819000},"page":"1521-1529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Choice of Hormone Assay to Monitor Feminizing Gender-Affirming Hormone Therapy"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5283-3130","authenticated-orcid":false,"given":"Daniel J.","family":"Slack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Garrity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Kyweluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Trakhtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrica","family":"Kirkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Safer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2025.08.010_bib1","series-title":"How many adults identify as transgender in the United States?","author":"Flores","year":"2022"},{"issue":"11","key":"10.1016\/j.eprac.2025.08.010_bib2","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: An Endocrine Society Clinical Practice Guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.08.010_bib3","first-page":"211","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgender Health"},{"key":"10.1016\/j.eprac.2025.08.010_bib4","article-title":"Examining the influence of the route of administration and dose of estradiol on serum etradiol and testosterone concentrations in feminizing gender-affirming hormone therapy","author":"Slack","year":"2024","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2025.08.010_bib5","article-title":"Follow-up estradiol concentrations based on regimen formulation with guideline-concordant gender-affirming hormone therapy","author":"Carlson","year":"2024","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.eprac.2025.08.010_bib6","article-title":"Injectable estradiol use in transgender and gender-diverse individuals throughout the United States","volume":"11","author":"Misakian","year":"2025","journal-title":"The J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2025.08.010_bib7","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae108","article-title":"Effectiveness and safety of different estradiol regimens in transgender females: a randomized controlled trial","volume":"8","author":"Cortez","year":"2024","journal-title":"J Endocr Soc"},{"issue":"9","key":"10.1016\/j.eprac.2025.08.010_bib8","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.eprac.2024.05.008","article-title":"The use of injectable estradiol in transgender and gender diverse adults: a scoping Review of dose and serum estradiol levels","volume":"30","author":"Rothman","year":"2024","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.eprac.2025.08.010_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/lgbt.2018.0116","article-title":"Assessment of gender-affirming hormone therapy requirements","volume":"6","author":"Fernandez","year":"2019","journal-title":"LGBT Health"},{"issue":"2","key":"10.1016\/j.eprac.2025.08.010_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.eprac.2023.11.011","article-title":"Serum hormone concentrations in transgender youth receiving estradiol","volume":"30","author":"Sumerwell","year":"2024","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.eprac.2025.08.010_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.eprac.2023.02.006","article-title":"Comparison of the subcutaneous and intramuscular estradiol regimens as part of gender-affirming hormone therapy","volume":"29","author":"Herndon","year":"2023","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.eprac.2025.08.010_bib12","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/cpt.2234","article-title":"Sex and gender differences in clinical pharmacology: implications for transgender medicine","volume":"110","author":"Cirrincione","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.eprac.2025.08.010_bib13","article-title":"A comprehensive review of estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone in the context of laboratory medicine to support women's health","volume":"18","author":"Greene","year":"2025","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.eprac.2025.08.010_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4158\/EP-2017-0116","article-title":"Testosterone concentrations achieved by medically treated transgender women in a United States endocrinology clinic cohort","volume":"24","author":"Liang","year":"2018","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.eprac.2025.08.010_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2017-01927","article-title":"Breast development in transwomen after 1 year of cross-sex hormone therapy: results of a prospective multicenter study","volume":"103","author":"de Blok","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.08.010_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/trgh.2017.0035","article-title":"Hormonal treatment of transgender women with oral estradiol","volume":"3","author":"Leinung","year":"2018","journal-title":"Transgender Health"},{"issue":"3","key":"10.1016\/j.eprac.2025.08.010_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/trgh.2020.0077","article-title":"Relationship between serum estradiol concentrations and clinical outcomes in transgender individuals undergoing feminizing hormone therapy: a narrative review","volume":"6","author":"Nolan","year":"2021","journal-title":"Transgender Health"},{"issue":"9","key":"10.1016\/j.eprac.2025.08.010_bib18","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.08.010_bib19","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae205","article-title":"Follow-up estradiol levels based on regimen formulation with guideline-concordant gender-affirming hormone therapy","volume":"9","author":"Carlson","year":"2025","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.eprac.2025.08.010_bib20","doi-asserted-by":"crossref","DOI":"10.1089\/lgbt.2024.0407","article-title":"Estradiol concentrations for adequate gender-affirming feminizing therapy: a systematic review","author":"Winston-McPherson","year":"2025","journal-title":"LGBT Health"},{"issue":"5","key":"10.1016\/j.eprac.2025.08.010_bib21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/nau.25097","article-title":"Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: an overview of treatment modality, monitoring, and risks","volume":"42","author":"Sudhakar","year":"2023","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"10.1016\/j.eprac.2025.08.010_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/cen.14633","article-title":"Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism","volume":"96","author":"Jayasena","year":"2022","journal-title":"Clin Endocrinology"},{"issue":"3","key":"10.1016\/j.eprac.2025.08.010_bib23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0022-5347(01)61781-6","article-title":"Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer","volume":"161","author":"Petersen","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.eprac.2025.08.010_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1184024","article-title":"Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations","volume":"14","author":"Sehgal","year":"2023","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.08.010_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/EJE-19-0463","article-title":"Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria","volume":"182","author":"Meyer","year":"2020","journal-title":"Eur J Endocrinol"}],"updated-by":[{"DOI":"10.1016\/j.eprac.2026.05.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000}},{"DOI":"10.1016\/j.eprac.2026.05.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25010201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25010201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:37:04Z","timestamp":1765967824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25010201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1530891X25010201"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.08.010","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Choice of Hormone Assay to Monitor Feminizing Gender-Affirming Hormone Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}